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Abstract
Objective:  to  test  the  clinical  utility  of  an  early  amplitude-integrated  electroencephalography
(aEEG) to  predict  short-term  neurological  outcome  in  term  newborns  at  risk  of  neurology  injury.
Methods:  this  was  a  prospective,  descriptive  study.  The  inclusion  criteria  were  neonatal  ence-
phalopathy, neurologic  disturbances,  and  severe  respiratory  distress  syndrome.  Sensitivity,
speciﬁcity,  positive  and  negative  predictive  values,  and  likelihood  ratio  (LR)  were  calculated.
Clinical  and  demographic  data  were  analyzed.  Neurological  outcome  was  deﬁned  as  the  sum  of
clinical,  electroimaging,  and  neuroimaging  ﬁndings.
Results:  ten  of  the  21  monitored  infants  (48%)  presented  altered  short-term  neurologic  out-
come.  The  aEEG  had  90%  sensitivity,  82%  speciﬁcity,  82%  positive  predictive  value,  and  90%
negative  predictive  value.  The  positive  LR  was  4.95,  and  the  negative  LR  was  0.12.  In  three  of
12  (25%)  encephalopathic  infants,  the  aEEG  allowed  for  a  better  deﬁnition  of  the  severity  of
their  condition.  Seizures  were  detected  in  eight  infants  (38%),  all  subclinical  at  baseline,  and
none  had  a  normal  aEEG  background  pattern.  The  status  of  three  infants  (43%)  evolved  and
required  two  or  more  drugs  for  treatment.
Conclusions:  in  infants  with  encephalopathy  or  other  severe  illness,  aEEG  disturbances  occur
frequently. aEEG  provided  a  better  classiﬁcation  of  the  severity  of  encephalopathy,  detected
early  subclinical  seizures,  and  allowed  for  monitoring  of  the  response  to  treatment.  aEEG  was
a  useful  tool  at  the  neonatal  intensive  care  unit  for  predicting  poor  short-term  neurological
outcomes  for  all  sick  newborn.
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Utilidade  clínica  de  um  monitoramento  por  EEG  de  amplitude  integrada  precoce  em
recém-nascidos  a  termo  com  risco  de  lesão  neurológica
Resumo
Objetivo:  testar  a  utilidade  clínica  do  aEEG  precoce  em  recém-nascidos  a  termo  com  risco  de
lesão  neurológica,  para  prever  resultados  neurológicos  de  curto  prazo.
Métodos: estudo  prospectivo  e  descritivo.  Os  critérios  de  inclusão  foram  encefalopatia  neona-
tal,  distúrbios  neurológicos  e  bebês  com  SARA  grave.  Sensibilidade,  especiﬁcidade,  valor
preditivo  positivo  e  negativo  e  razão  de  verossimilhanc¸a foram  calculados.  Dados  clínicos  e
demográﬁcos  foram  analisados.  O  resultado  neurológico  foi  deﬁnido  como  a  soma  de  conclusões
clínicas,  de  eletro  e  de  neuroimagem.
Resultados: dentre  os  21  neonatos  monitorados,  dez  (48%)  apresentaram  resultado  neurológico
de curto  prazo  alterado.  O  aEEG  apresentou  sensibilidade  de  90%,  especiﬁcidade  de  82%,  valor
preditivo  positivo  de  82%  e  valor  preditivo  negativo  de  90%.  A  VR  positiva  foi  de  4,95,  e  a  RV
negativa  de  0,12.  Em  três  dos  12  (25%)  neonatos  com  encefalopatia  foi  possível  deﬁnir  melhor
a  gravidade  de  sua  condic¸ão  pelo  aEEG.  Foram  detectadas  convulsões  em  oito  neonatos  (38%),
todas  subclínicas  no  início  do  estudo,  e  nenhum  apresentou  um  padrão  histórico  normal  no  aEEG.
O  estado  de  três  neonatos  (43%)  evoluiu  e  exigiu  dois  ou  mais  medicamentos  para  tratamento.
Conclusões:  em  neonatos  com  encefalopatia  ou  outra  doenc¸a grave,  os  distúrbios  no  aEEG
ocorrem com  mais  frequência.  O  aEEG  forneceu  uma  classiﬁcac¸ão  melhor  da  gravidade  da  ence-
falopatia,  detectou  convulsões  subclínicas  precoces  e  permitiu  que  fosse  feito  o  monitoramento
da  resposta  ao  tratamento.  O  aEEG  é  uma  ferramenta  útil  para  prever  resultados  neurológicos
de  curto  prazo  em  todos  os  bebês  doentes  na  UTIN.
©  2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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odern  neonatal  practices  involve  managing  increasingly  ill
nd complex  patients.  The  assessment  of  neurological  func-
ion of  these  patients  is  limited  by  the  severity  of  the  base
llness and  the  use  of  sedating  medications.  It  is  difﬁcult
o determine  which  patients  need  specialized  neurological
ollow-up after  a  neonatal  disease.
The  introduction  of  continuous  brain  monitoring  by
mplitude-integrated electroencephalography  (aEEG)
llows for  the  evaluation  of  brain  function  in  real  time
nd over  long  periods.  The  aEEG  wave  appears  to  be  the
esult of  the  sum  of  the  resting  membrane  potential,
hich is  inﬂuenced  primarily  by  the  metabolic  status  and
econdarily by  the  blood  ﬂow  to  the  brain,  among  other
actors. 1--4
While  the  evolution  of  aEEG  monitoring  after  hypoxic-
schemic events  has  proven  prognostic  value,5--10 its  utility
or other  common  neonatal  morbidities  has  not  been  well-
tudied. The  main  limitation  of  aEEG  monitoring  is  that
t provides  limited  information  regarding  electrical  brain
ctivity. The  monitored  areas  correspond  to  the  limit  of
rrigation of  the  three  cerebral  arteries  that  are  more
usceptible to  hypoxic-ischemic  insults.11 There  is  dis-
greement regarding  its  utility  for  detecting  seizures.12
nother  limitation  is  in  distinguishing  the  true  image  of
rtifacts.13
The  main  objective  of  this  study  was  to  assess  the
linical utility  of  an  early  aEEG  to  predict  short-term  neu-
ological outcomes  among  term  newborns  admitted  to  the
eonatal intensive  care  unit  (NICU)  at  risk  of  neurological
njury.
M
E
waterials and methods
atients
erm  newborns  from  the  period  of  September  of  2005  to
ugust of  2006  were  selected  for  aEEG  monitoring  if  they
ere considered  as  evolving  with  a  neurological  risk.  Thus,
ny babies  with  a  neonatal  encephalopathy,  neurologic  dis-
urbance, or  with  severe  respiratory  distress  syndrome  (RDS)
ere included.  Diagnoses  were  made  by  the  attending  physi-
ians based  on  clinical  and  laboratory  criteria.  In  hypoxic
schemic encephalopatic  (HIE)  neonates,  the  Sarnat  clas-
iﬁcation I-III  was  used  in  order  of  increasing  severity.9
ntry  criteria  for  hypothermia  protocol  were  term  infants,
ess than  6  hours  old,  with  acute  fetal  distress  (prolonged
esuscitation need,  and/or  cord  pH  <  7.0;  and/or  Apgar
core at  5  minutes  <  5),  evolving  encephalopathy,  and  an
ltered aEEG  record  after  the  ﬁrst  hour  of  life.  RDS  patients
ere monitored  when  they  reached  an  oxygenation  index
OI) >  18.  Extracorporeal  membrane  oxygenation  (ECMO)
reatment criteria  were  OI  >  40  after  maximum  respiratory
anagement, and  reversible  lung  disease.  Newborns  with  a
nown prenatal  brain  lesion  or  malformation  were  excluded,
s well  as  any  simultaneous  patients,  since  only  one  brain
onitor was  available.  The  study  was  approved  by  the  ethics
ommittee of  this  institution,  and  an  informed  consent  was
btained from  the  parents.onitoring
lectrodes  were  installed  on  patients’  shaved  scalps,  and
ere monitored  with  a  device  (BRM2  Brainz  Instruments)
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aUtility  of  amplitude  integrated  EEG  in  term  newborns  
that  provided  information  regarding  both  brain  hemi-
spheres, in  locations  equivalent  to  C3-P3  and  C4-P4  of  a
standard EEG.  This  device  ampliﬁes  the  signal  obtained  after
ﬁltration between  2  to  15  Hz,  integrates  information  from
the amplitude  of  the  waves  obtained,  and  then  scans  to  dis-
play patterns  on  the  screen  at  6  cm/h  and  raw  EEG  in  real
time. A  physician  (not  blinded),  assisted  by  medical  super-
visors trained  in  this  technique,  interpreted  the  tracings.
The information  was  stored  on  a  computer  hard  disk  and
extracted for  further  analysis  using  two  software  (Analyze
and Chart  Analyzer).  The  patterns  obtained  were  classiﬁed
according to  Hellström-Westas  classiﬁcation,  where  type  1
is normal,  and  types  2,  3,  4,  and  5  are  altered  in  increas-
ing order  of  severity.14 Monitoring  was  installed  as  soon  as
possible and  continued  until  patients  were  stable.  EEG  was
requested for  selected  episodes  as  a  standard  clinical  need.
The presence  and  management  of  seizures  were  registered,
as well  as  adverse  events  related  to  the  aEEG  technique.
The use  of  drugs  that  affect  the  central  nervous  system  was
recorded.15--18
Data  collection  and  outcome  measures
Demographic  and  clinical  data  were  prospectively  collected.
The main  outcome  was  short  term  neurological  evolution,
classiﬁed as  normal  or  abnormal.
The  abnormal  neurological  outcome  was  deﬁned  by
standard clinical  practices:  the  presence  of  an  altered
physical exam  (disturbances  in  consciousness,  hyper-  or
hypotonia, absent  visual  ﬁxation  and/or  absent  gag,  suck,
and feeding  autonomy)  documented  by  the  attending  physi-
cian after  the  acute  evolution  was  resolved,  combined  with
an altered  brain  imaging  (presence  of  gray  or  white  matter
injury, basal  ganglia  compromise,  and  hemorrhagic  and/or
stroke lesions)  and/or  altered  pre-discharge  EEG  (altered
background pattern,  persistent  depressed  voltage,  and/or
seizures). Neuroimaging  was  requested  based  on  clinical
need (head  ultrasound,  transmission  computed  tomography,
or magnetic  resonance  imaging),  and  performed  by  an  inde-
pendent neuroradiologist  blinded  to  the  clinical  and  aEEG
ﬁndings.
Analysis
Descriptive  data  were  presented  as  mean  ±  SD  or  median
(range), as  appropriate.  Two-  sided  Student’s  t-test,  with
95% of  conﬁdence  interval,  was  used  for  parametric
variables, and  the  Mann-Whitney  test  was  used  for  non-
parametric variables.  Categorical  variables  were  compared
through the  mid-p  exact  test.
Sensitivity,  speciﬁcity,  positive  and  negative  predictive
values, and  positive  and  negative  likelihood  ratios  (LR)  were
calculated  with  95%  conﬁdence  interval,  in  order  to  evaluate
whether aEEG  is  a  predictive  tool  for  short-term  neurological
evolution for  all  patients,  regardless  of  the  diagnosis.Results
During  the  study  period;  2,196  patients  were  born  at
this center  and  118  were  transferred  from  other  centers.
t
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f  these,  225  term  neonates  were  hospitalized  in  the
ICU. Twenty-one  newborns  were  monitored,  of  whom  13
ere outborns.  The  diagnoses  of  the  patients  included
ere: neonatal  encephalopathy  in  12  newborns  (ﬁve  began
ypothermia protocol),  pulmonary  hypertension  secondary
o RDS  in  eight  (four  began  ECMO),  and  one  with  suspected
eonatal seizures.  The  gestational  age  was  38.6  ±  1.4  weeks
mean ±  SD).  Monitoring  started  at  10  (4-20)  hours  [median
PC25-PC75)] of  life,  and  the  mean  duration  of  monitor-
ng was  54  (27-120)  hours;  1,626  hours  of  monitoring  were
btained. None  of  the  patients  died  during  the  study  period.
Patients’  demographic  and  clinical  characteristics  are
escribed on  Table  1.  Of  the  21  patients  studied,  ten  pre-
ented altered  short-term  neurological  outcome  as  deﬁned
hrough clinical,  EEG,  and/or  altered  neuroimaging  criteria.
he neurological  abnormal  babies  had  lower  Apgar  scores  at
ve minutes  than  the  normal  group,  and  were  more  likely
o develop  seizures  during  evolution.  The  group  of  abnormal
eurological outcome  was  mostly  represented  by  encepha-
opathy patients,  but  the  difference  was  not  statistically
igniﬁcant. The  three  patients  who  were  not  encephalo-
athic at  this  group,  also  had  a complicated  neurological
ourse, but  this  did  not  appear  to  be  attributable  to  an
schemic perinatal  hypoxic  event.  aEEG  was  abnormal  in
ine of  these  ten  newborns  (sensitivity  of  90%,  95%  CI:  59.6-
8.2).Of the  11  neurologically  normal  patients,  nine  also
ad a  completely  normal  aEEG  (speciﬁcity  of  82%,  95%  CI:
2.3-94.9). The  positive  predictive  value  was  82%  (95%  CI:
2.3-94.9) and  the  negative  predictive  value  was  90%  (95%
I: 59.6-98.2).  The  positive  LR  was  4.95  (95%  CI:  1.81-13.51)
nd the  negative  LR  was  0.12  (95%  CI:  0.02-0.91).
48%  of  the  newborns  started  with  a  normal  aEEG  pattern
nd progressed  normally  until  the  end  of  the  study.  None
f them  had  seizures.  The  recordings  showed  that  abnor-
al type  2,  3,  4,  and  5  aEEG  patterns  were  more  likely  to
ontinue to  be  altered.
38% of  the  children  had  seizures  during  monitoring.
ll detections  were  initially  performed  through  monitoring
ince there  were  about  three  hours  after  clinical  correlation
Fig. 1).  All  children  who  had  seizures  had  an  abnormal  aEEG
attern at  the  start  of  monitoring.  75%  of  the  newborns  that
volved to  a  convulsive  status  required  two  or  more  drugs
or the  treatment  of  seizures  (Fig.  2).
Of  the  12  encephalopathic  infants  (Table  2),  the  nor-
al recordings  of  ﬁve  helped  clinicians  to  decide  that  they
id not  require  hypothermia  protocol.  Two  encephalopathic
ewborns had  altered  aEEG  patterns,  but  came  late  to
ypothermia treatment  (which  is  recommended  to  start
efore 6  hours  of  life).  Patients  No.  3,  8,  and  12  had  symp-
oms of  HIE  grade  I at  the  time  of  evaluation,  but  the  aEEG
egistration showed  an  abnormal  path;  one  of  the  infants
ubsequently developed  seizures,  so  all  three  patients  actu-
lly evolved  into  a  HIE  grade  II  instead  of  a HIE  grade  I,  as
as the  ﬁrst  clinical  approach.
Standard  EEGs  were  performed  in  11  of  the  newborns
57%), and  the  results  were  consistent  with  those  of  the
EEG.
There were  no  adverse  local  or  general  events  related  to
he use  of  this  technique.  Artifacts  were  reported  in  29%  of
he patients,  associated  with  some  difﬁculties  with  the  aEEG
ensing signal,  especially  in  patients  with  scalp  edema  and  in
hree hypothermic  patients.  Intermittent  signals  were  due
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Table  1  Demographic  and  clinical  characteristics  of  the  study  group.
Neurologic  short  term  outcome
Abnormal (n  =  10)  Normal(n  =  11)  p-value
Birth  Weight,  kg  3,210  ±  457  3,309  ±  494  0.639
Gestational age,  weeks  38  ±  1  38  ±  1  0.999
Gender, n  (%male)  6  (60%)  6  (55%)  0.37
Apgar 5  minutesa 5  (1-9)  8  (6-8)  0.045
Presence of  any  grade  of  encephalopathy,  n  (%) 7 (70%) 5 (46%)  0.068
Presence of  an  abnormal  aEEG  pattern,  n  (%) 9 (90%) 2 (18%) < 0.001
Presence of  seizures,  n  (%) 7  (70%) 1 (9%) < 0.001
Data presented as mean ± SD, except where noted (a). a median (range).
aEEG, amplitude-integrated electroencephalography; SD, standard deviation.
EEG Waveform Left
EEG Waveform Right
aEEG Left
aEEG Right
Figure  1  Patient  with  severe  pulmonary  hypertension  secondary  to  a  dilated  cardiomiopathy  with  heart  failure.  On  the  third  day
of  life,  the  aEEG  showed  seizures  in  the  right  hemisphere.  Due  to  clinical  suspicion,  a  head  ultrasound  was  performed,  showing
intraventricular  hemorrhage  in  the  right  side  of  the  brain.  aEEG,  amplitude-integrated  electroencephalography.
EEG Waveform Left
EEG Waveform Right
aEEG Left
aEEG Right
67 8
867
Figure  2  Patient  with  a  suppressed  pattern  of  aEEG  evolves  to  status  epilepticus.  He  was  treated  with  60  mg/kg  of  phenobarbital
without effects  on  seizures.  The  arrow  shows  how  seizures  are  controlled  with  phenitoin,  and  base  line  becomes  more  suppressed.
aEEG,  amplitude-integrated  electroencephalography.
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Table  2  Clinical  and  aEEG  characteristics  of  encephalopathy  patients.
Patient  GA  (weeks)  Apgar  5  min  Cord  pH  Sarnat  HIE
grade
Start  of
recording
(hours  of  life)
Time of
registry  (hours)
Pattern aEEG
(Hellström-
Westas)
Hypothermia
1  39  2  6.89  I  4  25  1  No
2 40  1  6.76  III  3  149  5+s  Yes
3 40  2  6.95  I  8  87  2+s  Yes
4 40  9  7.1  I  5  16  1  No
5 40  2  6.96  I  6  16  1  No
6 38  3  6.98 II  12  87  3+s  No
7 40  5  6.96 I  9  10  1  No
8 37  2  6.8  I  5  27  3  Yes
9 39  6  6.84  II  1  53  2+s  Yes
10  37  4  6.85  II  22  138  5+s  Yes
11  40  7  6.91  I  2  23  1  No
12  37  6  N/A  I  17  50  3  No
a EEG, amplitude-integrated electroencephalography; GA, gestational age; HIE, hypoxic ischemic encephalopathy; N/A, not available;
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(s, seizures, N/A, not available).
to  sensors  coming  unstuck  and  in  the  case  of  one  newborn,
due to  high-frequency  ventilator  interference.
Discussion
Prior  and  Maynard  created  the  aEEG  in  the  1960s  to  mon-
itor adult  cardiac  patients.19 Since  the  late  1970s,  it  has
been used  with  newborns,  but  initially  only  in  Europe.20--23
The  need  to  identify  encephalopathic  newborns  with  high
neurological risk  led  to  the  development  of  this  tech-
nique in  parallel  with  multicenter  studies  of  hypothermia,24
motivating  its  use  in  the  rest  of  the  world.25 There  is
now increasingly  sophisticated  and  less  invasive  equipment.
Thus, this  study  was  designed  to  test  the  emerging  technol-
ogy in  order  to  better  understand  the  clinical  approach.
At  the  time  of  the  study,  approximately  10%  of  the  term
infants were  very  sick  and  qualiﬁed  for  aEEG  monitoring.
With the  inclusive  criteria  used  to  monitor  patients  at  this
NICU, early  aEEG  performed  as  a  good  diagnostic  test  to
predict poor  short-term  neurological  outcomes.  It  was  less
precise in  predicting  normal  outcomes,  where  the  common
diagnostic tools  were  helpful.
Among  the  most  notable  ﬁndings  was  that  over  half
of the  patients  showed  alterations  in  aEEG  recordings.
It was  also  found  that  patients  with  an  altered  aEEG
pattern were  more  likely  to  develop  seizures,  and  this
was not  only  observed  with  encephalopathy  patients.
Seizures were  initially  all  subclinical,  as  described  in  the
literature.26 However;  there  was  also  a  notable  latency
period between  the  onset  of  the  electrical  disturbance
and clinical  emergence  at  this  setting.  In  status  epilepticus
infants, two  or  more  drugs  were  needed  to  control  seizures,
and the  aEEG  helped  to  manage  the  anticonvulsivant
therapy.
A theme  of  discussion  is  whether  aEEG  is  needed  to
decide if  an  encephalopathic  newborn  is  a  candidate  for
cooling therapy.27 aEEG  has  been  used  for  the  inclusion  crite-
ria in  some  cooling  protocols,25,28 but  not  in  others.  In  the
present study,  it  was  observed  that  early  aEEG  monitoring,
i
w
especially  in  infants  with  apparent  grade  I HIE, 24 was  more
ffective than  clinical  assessment  alone  in  identifying  which
ncephalopathic patients  would  develop  serious  neurologi-
al conditions.  This  ﬁnding  becomes  more  important  when
onsidering that  the  time  to  decide  whether  a  child  is  a
andidate for  hypothermia  therapy  is  limited,  and  that  is
mportant to  correctly  initiate  this  crucial  therapy.
There  is  a  recent  prospective  study  of  use  of  early  aEEG  (<
 hours)  in  moderate  and  severe  encephalopathic  patients,
hich didn’t  present  any  advantage  compared  with  only
taging to  predict  long  term  neurological  outcome.29 That
tudy differs  in  both  the  patients  included  and  main  out-
ome; thus,  a  comparison  with  the  present  study  is  not
easible.
An unexpected  ﬁnding  was  the  inability  of  the  clinical
xamination to  distinguish  patients  evolving  with  a  severe
eurological condition  in  real-time  and  how  the  use  of  aEEG
nﬂuenced the  adoption  of  more  agile  therapies.  This  was
ost striking  in  RDS  patients.
The  main  limitations  of  the  study  were  the  small  num-
er of  patients,  and  the  absence  of  a  strict  protocol  for
otal monitoring  time  or  for  EEG  or  neuroimaging  request.
owever, this  scenario  is  similar  to  the  actual  practice  with
nfants in  the  NICUs.
The long-term  beneﬁts  of  the  use  of  aEEG  have  not  been
valuated. There  is  one  report  that,  among  patients  with
eizures in  the  neonatal  period,  the  subsequent  incidence
f epilepsy  was  much  lower  with  the  use  of  this  technique
han without  (9.4%  vs.  56%).30 Thus,  aEEG  appears  to  be  an
nteresting complementary  tool.
In  conclusion,  early  aEEG  at  the  NICU  allowed  for
ore accurate  diagnoses,  better  selection  of  patients  for
ypothermia therapy,  appropriate  detection  and  early  treat-
ent of  seizures,  and  selection  of  patients  for  neurological
ollow-up.
Brain monitoring  at  the  NICU  offers  many  possibilities;
t would  be  constructive  to  better  study  its  application
ith respiratory,  cardiologic,  and  ECMO  patients,  as  well  as
xtremely preterm  infants.
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